Home/Filings/4/0001493152-22-015066
4//SEC Filing

Brady Monica L. 4

Accession 0001493152-22-015066

CIK 0000868278other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 5:18 PM ET

Size

12.8 KB

Accession

0001493152-22-015066

Insider Transaction Report

Form 4
Period: 2022-05-23
Brady Monica L.
Chief Accounting Officer
Transactions
  • Tax Payment

    Common Stock, par value $0.0005

    2022-05-23$8.47/sh11,806$99,99734,872 total
  • Exercise/Conversion

    Option (right to buy)

    2022-05-2314,25035,750 total
    Exercise: $3.18Exp: 2025-12-03Common Stock (14,250 underlying)
  • Exercise/Conversion

    Common Stock, par value $0.0005

    2022-05-23$2.15/sh+25,000$53,75032,428 total
  • Exercise/Conversion

    Common Stock, par value $0.0005

    2022-05-23$3.18/sh+14,250$45,31546,678 total
  • Exercise/Conversion

    Option (right to buy)

    2022-05-2325,0000 total
    Exercise: $2.15Exp: 2024-09-26Common Stock (25,000 underlying)
Footnotes (3)
  • [F1]On May 23, 2022, the Reporting Person acquired net 27,444 shares of common stock upon the exercise of stock options to purchase 39,250 shares of common stock, less 11,806 shares of common stock withheld to cover the exercise price and applicable taxes.
  • [F2]25% of the shares subject to this option were vested and exercisable as of September 26, 2017, the date of grant, and the remaining 75% of the shares vested in three annual installments beginning on September 26, 2018.
  • [F3]These options vest in four equal annual installments beginning December 4, 2019, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of December 4, 2018.

Documents

1 file

Issuer

ProPhase Labs, Inc.

CIK 0000868278

Entity typeother

Related Parties

1
  • filerCIK 0001718729

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 5:18 PM ET
Size
12.8 KB